Evidence map›Paper›PMID 42259797›Full record

ArticleNature communications2026

Overprinting with tomographic volumetric additive manufacturing.

Felix Wechsler, Viola Sgarminato, Riccardo Rizzo, Baptiste Nicolet, Wenzel Jakob, Christophe Moser

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Felix WechslerLaboratory of Applied Photonics Devices, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland. overprinting@felixwechsler.science.ORCID http://orcid.org/0000-0001-8763-2948
Viola SgarminatoLaboratory of Applied Photonics Devices, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-7633-5478
Riccardo RizzoLaboratory of Applied Photonics Devices, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Baptiste NicoletRealistic Graphics Lab, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Wenzel JakobRealistic Graphics Lab, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland. wenzel.jakob@epfl.ch.
Christophe MoserLaboratory of Applied Photonics Devices, École polytechnique fédérale de Lausanne (EPFL), Lausanne, Switzerland. christophe.moser@epfl.ch.ORCID http://orcid.org/0000-0002-2078-0273

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 10007068Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) P5R5-3_235066
6 · The paper itself

Abstract

Tomographic Volumetric Additive Manufacturing (TVAM) is a light-based 3D printing technique capable of producing centimeter-scale objects within seconds. A key challenge lies in the calculation of tomographic projection patterns under non-standard conditions, such as the presence of occlusions and materials with diverse optical properties, including varying refractive indices or scattering surfaces.This work demonstrates a broad range of overprinting scenarios, where new structures are directly printed onto or around pre-existing components made from different materials. Our simulations and experimental verifications perform overprinting of absorbing, refracting, reflecting and scattering elements in both round and square vials.All scenarios are optimized with our differentiable, physically based ray-optics approach using the open-source Dr.TVAM framework, delivering high-quality projections for both laser- and LED-based illuminations within minutes and lower-quality projections within seconds, exceeding existing open-source solutions in speed, flexibility, and quality.

Identifiers

PMID42259797
PMCPMC13402308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.